	Phase Iâ€“II study
Capecitabine
Oxaliplatin
Radiotherapy
Rectal cancer
Chemoradiation
	dose
rectal cancer
resection
phase II study
National Cancer Institute
tumor
patients
surgery
studies
radiotherapy
week
days
grade 2 diarrhea
maximum-tolerated dose
local recurrence rate
clinical outcome
pCR
oxaliplatin
treatment cycle
capecitabine
total
local cure
delay
endopelvic fascia
DLT
results

